Company news

Ascentage Pharma Group International news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Ascentage Pharma to Participate in Evercore China Biotech Summit

August 1, 2025

Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025

July 23, 2025

Ascentage Pharma Announces Pricing of Top-Up Placement

July 14, 2025

Ascentage Pharma Announces Proposed Top-Up Placement

July 14, 2025

Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL

July 10, 2025

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance

July 7, 2025

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

June 15, 2025

Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress

June 9, 2025

Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors

June 2, 2025

Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report

June 2, 2025

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025

May 22, 2025

Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax

April 28, 2025

Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin

April 23, 2025

← Newer news releases

Calls

Decks

The 5 newest of 14 decks. Every deck is listed under its year.